NASHVILLE, Tenn. / Oct 04, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 3Q Earnings Release Call | ||
When: | Tuesday, October 24, 2023 at 9:00 am central (10:00 am eastern) | ||
How: | Live Audio over the Internet: | ||
CLICK HERE TO REGISTER | |||
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$381.39 |
| Daily Change: | 2.74 0.72 |
| Daily Volume: | 2,095,552 |
| Market Cap: | US$96.610B |
April 25, 2025 February 20, 2025 February 18, 2025 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
